图片展示

图片展示

图片展示

图片展示

  • 繁體中文
  • English
图片展示
图片展示

Early Detection, Early Treatment, Higher Survival Rate [1]

4/5 Survival Chance

1/5 Survival Chance

4/5 ← Survival Chance → 1/5

图片展示

[1]Cancer Survival in England. NHS Digital. 2022

4/5 Survival Chance

1/5 Survival Chance

4/5 ← Survival Chance → 1/5

图片展示

[1]Cancer Survival in England. NHS Digital. 2022

Treatment costs increase with cancer advancement.

Spend less if cancer is detected at early stage. enables regular and early monitoring of cancer health risk.

A New Generation of Health Screening Method

We  you the risk of

cancer progression the soonest we can. 

Circulating Tumour Cell Test

Patented Technology Developed by the research group of City 

University of Hong Kong

CanTell CTC test is based on an innovative and patented technologies that captures and identifies circulating tumour cells (CTCs) in blood. By tracking the variations of individual tests from time to time, we can provide reliable and traceable reference for changes of health conditions including tumour development. Early detection, early treatment, higher survival rate.  

No data

Spend less if cancer is detected at early stage.

 enables regular and early monitoring of cancer health risk.

A New Generation of Health Screening Method

We  you the risk of

cancer progression the soonest we can. 

Circulating Tumour Cell Test


Patented Technology Developed by the research group of City 

University of Hong Kong


CanTell CTC test is based on an innovative and patented technologies that captures and identifies circulating tumour cells (CTCs) in blood. By tracking the variations of individual tests from time to time, we can provide reliable and traceable reference for changes of health conditions including tumour development. Early detection, early treatment, higher survival rate.  

award4
award3
award2
award1
No data

We care for your health

" To get the test, please leave us your contact. "

  • Name: *

  • Email: *

  • Telephone no:

  • Submit

  • Security Code
    Refresh the code
    Cancel
    Confirm

Cellomics International Ltd. 

R&D Laboratory

Email: info@cellomicsbio.com

Tel:+852 27083218

Cellomics Medical Laboratory 

Medical Laboratory and Main Office 

Email: info@cellomicsbio.com

Tel: +852 27083633 / +852 27083108

Cellomics International Limited is the wholly-owned subsidiary of Cellomics Holdings Limited. 

Cellomics International Ltd. 

R&D Laboratory

Email: info@cellomicsbio.com

Tel:+852 27083218

Cellomics Medical Laboratory 

Medical Laboratory and Main Office 

Email: info@cellomicsbio.com

Tel: +852 27083633 / +852 27083108

Cellomics International Limited is the wholly-owned subsidiary of Cellomics Holdings Limited.

Add WeChat friend to learn more about the product
Use Enterprise WeChat
"Scan" to join the group chat
Copy success!
Add WeChat friend to learn more about the product
I see.